The company behind popular weight loss drug Mounjaro has offered a discounted deal to UK suppliers which is expected to limit the price increase to consumers from September.
Earlier this month, Eli Lilly announced it was putting up the list price of the drug by as much as 170% which could have meant the cost of the highest dose going up from £122 to £330 per month.
But the BBC understands the highest dose will now be sold to suppliers for £247.50.
Pharmacies and other private weight-loss services will add their own mark-up to consumers, but it means the price rise for patients is unlikely to be as large as initially feared.
Eli Lilly originally said the UK price of Mounjaro had to increase to be more in line with higher prices in Europe and the US.
